1098 related articles for article (PubMed ID: 28747266)
21. Bullous pemphigoid and related subepidermal autoimmune blistering diseases.
Olasz EB; Yancey KB
Curr Dir Autoimmun; 2008; 10():141-66. PubMed ID: 18460884
[TBL] [Abstract][Full Text] [Related]
22. Complement-Activating Capacity of Autoantibodies Correlates With Disease Activity in Bullous Pemphigoid Patients.
Chiorean RM; Baican A; Mustafa MB; Lischka A; Leucuta DC; Feldrihan V; Hertl M; Sitaru C
Front Immunol; 2018; 9():2687. PubMed ID: 30524436
[No Abstract] [Full Text] [Related]
23. [Autoimmune blistering diseases].
Duvert-Lehembre S; Joly P
Rev Med Interne; 2014 Mar; 35(3):166-73. PubMed ID: 23747156
[TBL] [Abstract][Full Text] [Related]
24. IgG4 autoantibodies induce dermal-epidermal separation.
Mihai S; Chiriac MT; Herrero-González JE; Goodall M; Jefferis R; Savage CO; Zillikens D; Sitaru C
J Cell Mol Med; 2007; 11(5):1117-28. PubMed ID: 17979887
[TBL] [Abstract][Full Text] [Related]
25. In vitro organ culture model for mucous membrane pemphigoid.
Colón JE; Bhol KC; Razzaque MS; Ahmed AR
Clin Immunol; 2001 Feb; 98(2):229-34. PubMed ID: 11161979
[TBL] [Abstract][Full Text] [Related]
26. Antibodies to desmogleins 1 and 3, but not to BP180, induce blisters in human skin grafted onto SCID mice.
Zillikens D; Schmidt E; Reimer S; Chimanovitch I; Hardt-Weinelt K; Rose C; Bröcker EB; Kock M; Boehncke WH
J Pathol; 2001 Jan; 193(1):117-24. PubMed ID: 11169524
[TBL] [Abstract][Full Text] [Related]
27. Oral Lesions in Autoimmune Bullous Diseases: An Overview of Clinical Characteristics and Diagnostic Algorithm.
Rashid H; Lamberts A; Diercks GFH; Pas HH; Meijer JM; Bolling MC; Horváth B
Am J Clin Dermatol; 2019 Dec; 20(6):847-861. PubMed ID: 31313078
[TBL] [Abstract][Full Text] [Related]
28. Pathogenesis of bullous pemphigoid.
Ujiie H; Nishie W; Shimizu H
Immunol Allergy Clin North Am; 2012 May; 32(2):207-15, v. PubMed ID: 22560134
[TBL] [Abstract][Full Text] [Related]
29. Coexistence of pemphigus vulgaris and bullous pemphigoid in the upper aerodigestive tract.
Tabuchi K; Nomura M; Murashita H; Fujisawa Y; Tsuji S; Okubo H; Hara A
Auris Nasus Larynx; 2006 Jun; 33(2):231-3. PubMed ID: 16168587
[TBL] [Abstract][Full Text] [Related]
30. Serum and blister fluid anticomplementary activity in pemphigus and bullous pemphigoid. Sucrose density gradient studies.
Jordon RE; McDuffie FC
Proc Soc Exp Biol Med; 1976 Mar; 151(3):594-8. PubMed ID: 768993
[TBL] [Abstract][Full Text] [Related]
31. Complement and cutaneous autoimmune blistering diseases.
Lessey E; Li N; Diaz L; Liu Z
Immunol Res; 2008; 41(3):223-32. PubMed ID: 18641925
[TBL] [Abstract][Full Text] [Related]
32. Autoantibodies to bullous pemphigoid antigen 180 induce dermal-epidermal separation in cryosections of human skin.
Sitaru C; Schmidt E; Petermann S; Munteanu LS; Bröcker EB; Zillikens D
J Invest Dermatol; 2002 Apr; 118(4):664-71. PubMed ID: 11918714
[TBL] [Abstract][Full Text] [Related]
33. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid.
Shimanovich I; Mihai S; Oostingh GJ; Ilenchuk TT; Bröcker EB; Opdenakker G; Zillikens D; Sitaru C
J Pathol; 2004 Dec; 204(5):519-27. PubMed ID: 15538734
[TBL] [Abstract][Full Text] [Related]
34. Bullous pemphigoid complicated with pemphigus vulgaris?
Ninomiya J; Nakabayashi A; Sei Y; Takiuchi I
Dermatology; 1994; 189 Suppl 1():117-9. PubMed ID: 8049549
[TBL] [Abstract][Full Text] [Related]
35. IgG subclasses of intercellular and basement membrane zone antibodies: the relationship to the capability of complement fixation.
Yamada H; Hashimoto T; Nishikawa T
J Invest Dermatol; 1989 Apr; 92(4):585-7. PubMed ID: 2649595
[TBL] [Abstract][Full Text] [Related]
36. Combined features of pemphigus foliaceus and bullous pemphigoid: immunoblot and immunoelectron microscopic studies.
Ishiko A; Hashimoto T; Shimizu H; Masunaga T; Nishibori Y; Watanabe K; Nishikawa T
Arch Dermatol; 1995 Jun; 131(6):732-4. PubMed ID: 7778933
[No Abstract] [Full Text] [Related]
37. [Immunologic phenomena in the skin of patients with pemphigoid in relation to the pathologic process].
Torzecka JD; Lutowiecka-Wranicz A; Sysa-Jedrzejowska A; Waszczykowska E; Dziankowska-Bartkowiak B
Przegl Dermatol; 1988; 75(4):266-71. PubMed ID: 3070636
[No Abstract] [Full Text] [Related]
38. Autoimmune bullous dermatoses.
Cunha PR; Barraviera SR
An Bras Dermatol; 2009; 84(2):111-24. PubMed ID: 19503978
[TBL] [Abstract][Full Text] [Related]
39. Human amnion membrane as a substrate for the detection of autoantibodies in pemphigus vulgaris and bullous pemphigoid.
Sezin T; Avitan-Hersh E; Indelman M; Moscona R; Sabo E; Katz R; Pollack S; Bergman R
Isr Med Assoc J; 2014 Apr; 16(4):217-23. PubMed ID: 24834757
[TBL] [Abstract][Full Text] [Related]
40. Coexistence of pemphigus and bullous pemphigoid.
Matsubara K; Kanauchi H; Tanaka T; Imamura S
J Dermatol; 1995 Jan; 22(1):68-71. PubMed ID: 7897029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
